Historical collection · First published Mar 23, 2026; added to EM Weekly Oct 27, 2026. This retrospective summary may be superseded by later evidence or guidance.
← All articlesSurviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026
Summary
The adult update provides 129 statements, including 46 new statements. For ED care, it retains rapid antibiotics for shock or probable/definite sepsis, permits rapid investigation for possible sepsis without shock, and frames initial fluids as a conditional recommendation requiring repeated reassessment.
Why it matters
Distinguish possible infection without shock from high-likelihood sepsis and shock when setting antibiotic urgency. Do not delay necessary vasopressors solely for central access.
Study at a glance
- Design
- Guideline
- Population
- Adults with sepsis or septic shock, including immediate prehospital and hospital care.
- Sample size
- Not applicable
- Intervention
- Updated screening, antimicrobials and hemodynamic management recommendations.
- Comparator
- 2021 SSC guideline.
- Primary endpoint
- GRADE-based recommendations rather than one trial outcome.
Main findings
- For sepsis-induced hypoperfusion or septic shock, at least 30 mL/kg IV crystalloid within three hours is conditional, with low-certainty evidence and ongoing reassessment.
- An initial MAP target of 65 mm Hg is strong with moderate-certainty evidence.
- Peripheral initiation of vasopressors rather than waiting for central access is conditional, with very-low-certainty evidence.
Limitations
Several immediately relevant recommendations rest on low or very-low-certainty evidence. Fixed fluid volumes and MAP targets require clinical context; later 2026 trials were not necessarily incorporated.
Recommendation strength
Mixed GRADE strengths; examples are reported individually in findings. A strong recommendation does not imply high-certainty evidence.
Read the primary source
Full text: Official society summary available.
Original sourceDOI: 10.1007/s00134-026-08361-1
Material reviewed: official society summary.
Source retrieved Oct 27, 2026. Current SCCM recommendation table reviewed. Springer verifies March 23 online date; May is the print issue. The May 5 correction (10.1007/s00134-026-08410-9) concerns four author names with stray trailing letters, according to the public correction abstract at https://researchinformation.umcutrecht.nl/en/publications/publisher-correction-surviving-sepsis-campaign-international-guid/ . No clinical recommendation changes are stated there. Complete guideline and subscription-only correction PDF were not reviewed.
Corrections & review history
No corrections recorded. Human review: not yet human-reviewed.